U.S. markets close in 55 minutes

Kymera Therapeutics, Inc. (KYMR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
59.91+1.75 (+3.02%)
As of 3:04PM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 7/25/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 374.83%
S&P500 52-Week Change 336.19%
52 Week High 391.92
52 Week Low 325.43
50-Day Moving Average 350.20
200-Day Moving Average 351.57

Share Statistics

Avg Vol (3 month) 3499.65k
Avg Vol (10 day) 3458.52k
Shares Outstanding 549.79M
Implied Shares Outstanding 6N/A
Float 29.45M
% Held by Insiders 19.12%
% Held by Institutions 168.41%
Shares Short (Jun 29, 2021) 42.36M
Short Ratio (Jun 29, 2021) 44.36
Short % of Float (Jun 29, 2021) 46.85%
Short % of Shares Outstanding (Jun 29, 2021) 45.23%
Shares Short (prior month May 27, 2021) 41.96M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021


Profit Margin -96.81%
Operating Margin (ttm)-97.81%

Management Effectiveness

Return on Assets (ttm)-9.34%
Return on Equity (ttm)-30.81%

Income Statement

Revenue (ttm)49.31M
Revenue Per Share (ttm)1.76
Quarterly Revenue Growth (yoy)445.60%
Gross Profit (ttm)-28.07M
EBITDA -47.06M
Net Income Avi to Common (ttm)-47.74M
Diluted EPS (ttm)-1.70
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)333.54M
Total Cash Per Share (mrq)7.42
Total Debt (mrq)17.47M
Total Debt/Equity (mrq)6.35
Current Ratio (mrq)3.09
Book Value Per Share (mrq)6.13

Cash Flow Statement

Operating Cash Flow (ttm)77.36M
Levered Free Cash Flow (ttm)32.18M